Air sampling at four US airports in 2023 and 2024 detected SARS-CoV-2, the virus that causes COVID-19, in over 98% of samples and influenza A in over 17%, according to a study published in PLOS Global Public Health.
Researchers from the Centers for Disease Control and Prevention led the study, which involved air monitoring in congregate areas at San Francisco International Airport, Newark Liberty International Airport, Washington Dulles International Airport, and Dallas/Fort Worth International Airport.
The team placed samplers on tables 28 to 30 inches above the floor near customs and immigration inspection areas and international arrivals. Each ThermoFisher AerosolSense unit collected air samples for 10 hours per day, and the sample-collection cartridges were removed after 20 hours of use Monday through Thursday and 30 hours over the weekend.
Correlation of the air samples with aviation wastewater, traveler nasal swabs, and national clinical surveillance data was also tested using data from two airports.
Air sampling complements wastewater monitoring, the researchers said: “This approach is particularly effective for capturing respiratory pathogens from diverse populations, including asymptomatic or pre-symptomatic individuals who might not otherwise engage with clinical testing or contribute to accessible wastewater systems.”
May be a component of pandemic preparedness
Polymerase chain reaction (PCR) testing revealed SARS-CoV-2 in 98.3% of 463 air samples and influenza A in 17.2%. While influenza A positivity correlated with that in aviation wastewater, traveler nasal swabs, and national clinical surveillance, SARS-CoV-2 positivity didn’t align well.
Detection of respiratory pathogens through air monitoring may inform targeted mitigation strategies, including enhanced ventilation, air purification, public health messaging, and allocation of public health resources.
Genetic sequencing of SARS-CoV-2 from air samples identified lineages also found in wastewater samples during the same period from the same airports. In addition, it detected 30 viral species and recovered high-quality genomes for SARS-CoV-2, influenza, bocavirus (a virus that mainly causes respiratory tract and gastrointestinal infections in infants and young children), and seasonal coronaviruses.
“Air detection of viral pathogens within airports and other international points of entry may represent an important component of layered surveillance systems for future pandemic preparedness,” the authors wrote.
“Detection of respiratory pathogens through air monitoring may inform targeted mitigation strategies, including enhanced ventilation, air purification, public health messaging, and allocation of public health resources,” they wrote.